Posted by Michael Wonder on 03 Nov 2020
Fury as ‘life-changing’ eczema drug fails to make PBS
3 November 2020 - A “life-changing” drug was supposed to be approved for the Pharmaceutical Benefits Scheme months ago, but eczema sufferers are still forking out a whopping $1600 per month to purchase the medication.
The drug, called Dupixent, delivered by injection, has been hailed for its miraculous ability to repair the raw, cracked and itchy skin of eczema sufferers.
It was set to be approved for the Pharmaceutical Benefits Scheme in April, but seven months later, sufferers are still being forced to fork out $1,600/month to buy the medication.
Eczema Support Australia has written an open letter to the Pharmaceutical Benefits Advisory Committee, which will meet on Wednesday to reconsider if the drug should be made available on the scheme.
